Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Multiple-Dose Study of Oral ITF 2357 in Advanced Multiple Myeloma
2005-001084-56Phase 2Terminated
- Sponsor
- Italfarmaco
- Start
- Jun 2005
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of givinostat in multiple myeloma (MM), sponsored by Italfarmaco. Started Jun 2005; status: terminated.
02
Drugs
givinostat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2005-001084-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001084-56.